Reverse-Loop Upper Arm Arteriovenous Graft - Full Text View

Purpose

Background: A conventional configured prosthetic arteriovenous graft (AVG) usually wastes most upper arm vessels that a reverse-loop design may conserve. This study examined the feasibility of the AVG construction and its outcome.

Methods: Retrospective review of clinical outcomes of reverse-loop upper arm AVG patients. Measures included hemodialysis function, duplex scan, procedural complications, and follow-up interventions

Condition

Blood Vessel Prosthesis

MedlinePlus related topics:

Dialysis Kidney Failure

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Retrospective

Official Title:	Reverse-Loop Upper Arm Arteriovenous Graft for Chronic Hemodialysis

Further study details as provided by Far Eastern Memorial Hospital:

Primary Outcome Measures:

functional event-free primary patency [ Time Frame: event-free time ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Measures included hemodialysis function, duplex scan, procedural complications, and follow-up interventions. [ Time Frame: events (month) ] [ Designated as safety issue: No ]

Biospecimen Retention: Samples Without DNA

Biospecimen Description:

prosthetic vascular graft (ePTFE)

Enrollment:	7
Study Start Date:	January 2008
Estimated Study Completion Date:	December 2008
Estimated Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)

Groups/Cohorts

1

surgical outcome, observation

Eligibility

Ages Eligible for Study:	16 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

uremic patient, compromized forarm and elbow options

Criteria

Inclusion Criteria:

compromized forearm and elbow options

Exclusion Criteria:

unstable

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00708825

Locations


Taiwan, Taipei
	Far Eastern Memorial Hospital
	Pan-Chiao, Taipei, Taiwan, 220

Sponsors and Collaborators

Far Eastern Memorial Hospital

Min-Sheng General Hospital

Investigators


Principal Investigator:	Chih-Yang Chan, MD, PhD	Far Eastern Memorial Hospital

More Information

Responsible Party:	Far Eastern Memorial Hospital ( Chih-Yang Chan, MD, PhD )
Study ID Numbers:	FEMH 97018
First Received:	June 30, 2008
Last Updated:	June 30, 2008
ClinicalTrials.gov Identifier:	NCT00708825
Health Authority:	Taiwan: Department of Health

ClinicalTrials.gov processed this record on November 04, 2008

Sponsors and Collaborators:	Far Eastern Memorial Hospital Min-Sheng General Hospital
Information provided by:	Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:	NCT00708825